Latest Information
September 25, 2015

New studies of two drugs, showing that each works better than the standard treatment for advanced kidney cancer, should lead to changes in patient care, researchers said on Friday.

September 10, 2015

Researchers who studied a population-based cohort of patients with metastatic renal cell carcinoma (mRCC) found a trend toward improved survival with the shift from the cytokine to the targeted therapy era. The degree of improvement, however, was slightly less than that observed in clinical trials of targeted therapies.

August 12, 2015

Smoking is a risk factor in the clear cell and papillary subtypes of renal cell carcinoma (RCC), but not in chromophobe RCC, according to a study published in The Journal of Urology.

Print this page Tell A Friend Add to Favorites

Dr. Anil Kapoor

Dr. Anil Kapoor



Director of Research, Division of Urology
Program Director, Urology Residency Program
Surgical Director, Renal Transplantation, St. Joseph’s Hospital
Chair, Genito-Urinary Oncology Program, Juravinski Cancer Centre


St. Josephs Healthcare
Institute of Urology
50 Charlton Ave E, Room G344
Hamilton, ON L8N 4A6

Support Staff:
Cheryl Boult (Administrative Assistant)
Phone: (905) 522-1155 ext. 33218

Liz Sidorkewicz (Research Coordinator)
Phone: (905) 522-1155 ext. 35214

Clinical Interest

Main area of research focus is kidney disease, including renal cell carcinoma and renal transplantation. Recent investigations include cell signaling pathways involved in localized and metastatic renal cell cancer, examining the role of pTEN, cdk11, and the mTOR pathway; and therapeutic targeting of the mTOR pathway using the mTOR inhibitors, in metastatic renal cell cancer. In the transplant field, examination of the role of mTOR inhibitors in allograft function and malignancy including the cell signaling pathways. Other areas of research interest include the role of minimally invasive surgery in the treatment of urologic malignancies, including robotic platforms.


B.Sc., Dalhousie University
B.Engr., McGill University
M.D., Dalhousie University
Urology Residency, University of Manitoba
F.R.C.S. (C)- Urology
Renal Transplant and Renovascular Surgery Fellowship, Cleveland Clinic Foundation (USA)

Awards and Professional Affiliations

St. Joseph’s Healthcare Medical Staff Education Award (2004)
Canadian Urological Association Foundation Scholar (2000-2001)
Young Investigator Travel Award, Transplantation Society Sixth Basic Sciences Symposium (1999)
Lower Fellowship Thesis Award, Honorable Mention, Cleveland Clinic Foundation (1999)
First Prize, Ohio Urological Society (OUS) Essay Contest, Annual Meeting (1999)
First Prize, American College of Surgeons (ACS) Annual Scientific Meeting (1995)
First Prize, Resident's Research Colloquium Competition, Department of Surgery, University of Manitoba (1995)
CSCI/MRC National Resident's Research Award, University of Manitoba (1995-1996)
Best Poster Presentation, American Urological Association Meeting, Las Vegas (1995)

Father Sean O’Sullivan Research Centre
American Society of Transplantation
Canadian Society of Transplantation
American Urological Association
Canadian Urological Association
Canadian Medical Association
Ontario Medical Association
Hamilton Academy of Medicine,
EndoUrological Society
Canadian Urology Research Consortium
Canadian Academy of Urological Surgeons
Canadian Urologic Oncology Group